TY - JOUR
T1 - Hippocampal serotonin re-uptake and nocturnal locomotor activity after microinjections of 5,7-DHT in the fornix-fimbria
AU - Williams, Jonathan H.
AU - Azmitia, Efrain C.
N1 - Funding Information:
This investigation was supported by a post-doctoral fellowship to E.C.A. from NIH, by the H.E. Durham Fund (King's College, Cambridge), and by the Wellcome Trust. Present support for this work is provided by NSF Grant BNS-7906474 and a Hirschl Trust Career Scientist Award to E.C.A.
PY - 1981/2/23
Y1 - 1981/2/23
N2 - The role of the hippocampal 5-hydroxytryptamine (5-HT) terminals in the control of locomotor activity was investigated by lesioning 5-HT axons in the fimbria with 5,7-dihydroxytryptamine (5,7-DHT). Rats pretreated with desimipramine (10 mg/kg, i.p.) received microinjections of 5,7-DHT (0, 1, 3, 5 or 10 μg in 0.4 μl ascorbic Ringer's solution) into the fornix-fimbria. On the fourteenth to twenty-first nights after operation, nocturnal locomotor activity was measured in photocell cages. Twenty-eight to thirty days after operation degeneration of 5-HT terminals was assessed by measuring in vitro [3H]5-HT re-uptake in slices of dorsal hippocampus, ventral hippocampus and the septum. Groups injected with 5,7-DHT showed hyperactivity in the night period and increased decrements of activity between tests, both of which were related to the dose of neurotoxin. A reduction of [3H]5-HT re-uptake was found in dorsal hippocampus which was related to the dose of 5,7-DHT, but ventral hippocampal and septal [3H]5-HT re-uptake were not systematically reduced. For each rat, levels of dorsal and ventral hippocampal [3H]5-HT re-uptake were negatively correlated with the mean nocturnal activity from the 7 nights of testing. Levels of dorsal, but not ventral hippocampal [3H]5-HT re-uptake were negatively correlated with the mean nightly decrement of activity. No correlations were found between septal [3H]5-HT and these activity measures. These results, indicate that the increase in nocturnal locomotor activity caused by generalized depletion of 5-HT in the brain may be due to disruption of hippocampal 5-HT terminals supplied by the fornix-fimbria.
AB - The role of the hippocampal 5-hydroxytryptamine (5-HT) terminals in the control of locomotor activity was investigated by lesioning 5-HT axons in the fimbria with 5,7-dihydroxytryptamine (5,7-DHT). Rats pretreated with desimipramine (10 mg/kg, i.p.) received microinjections of 5,7-DHT (0, 1, 3, 5 or 10 μg in 0.4 μl ascorbic Ringer's solution) into the fornix-fimbria. On the fourteenth to twenty-first nights after operation, nocturnal locomotor activity was measured in photocell cages. Twenty-eight to thirty days after operation degeneration of 5-HT terminals was assessed by measuring in vitro [3H]5-HT re-uptake in slices of dorsal hippocampus, ventral hippocampus and the septum. Groups injected with 5,7-DHT showed hyperactivity in the night period and increased decrements of activity between tests, both of which were related to the dose of neurotoxin. A reduction of [3H]5-HT re-uptake was found in dorsal hippocampus which was related to the dose of 5,7-DHT, but ventral hippocampal and septal [3H]5-HT re-uptake were not systematically reduced. For each rat, levels of dorsal and ventral hippocampal [3H]5-HT re-uptake were negatively correlated with the mean nocturnal activity from the 7 nights of testing. Levels of dorsal, but not ventral hippocampal [3H]5-HT re-uptake were negatively correlated with the mean nightly decrement of activity. No correlations were found between septal [3H]5-HT and these activity measures. These results, indicate that the increase in nocturnal locomotor activity caused by generalized depletion of 5-HT in the brain may be due to disruption of hippocampal 5-HT terminals supplied by the fornix-fimbria.
KW - 5,7-DHT
KW - fornix-fimbria
KW - hippocampus
KW - locomotor activity
KW - re-uptake
KW - septum
KW - serotonin
UR - http://www.scopus.com/inward/record.url?scp=0019429342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019429342&partnerID=8YFLogxK
U2 - 10.1016/0006-8993(81)90681-8
DO - 10.1016/0006-8993(81)90681-8
M3 - Article
C2 - 7470907
AN - SCOPUS:0019429342
SN - 0006-8993
VL - 207
SP - 95
EP - 107
JO - Brain Research
JF - Brain Research
IS - 1
ER -